[Definitions and epidemiology of varicose vein disease].
| Autor: | Josnin M; Service de phlébologie interventionnelle, clinique Saint-Charles, La Roche-sur-Yon, France. Société française de phlébologie., Neaume N; Société française de phlébologie. Service de phlébologie interventionnelle, clinique Pasteur, Toulouse, France. |
|---|---|
| Jazyk: | francouzština |
| Zdroj: | La Revue du praticien [Rev Prat] 2024 Sep; Vol. 74 (7), pp. 732-737. |
| Abstrakt: | DEFINITIONS AND EPIDEMIOLOGY OF VARICOSE VEIN DISEASE. Chronic superficial venous disorders are a frequent reason for medical consultation. Depending on the study, between 20% and 60% of the general population suffer from varicose veins of the lower limbs. The socio-economic cost of venous disease is considerable, accounting for between 1% and 3% of national healthcare budgets. The factors leading to the formation of varicose veins and the pathogenesis are not clearly elucidated, but two factors have been identified: weakness of the venous wall and hemodynamic disorders. Symptoms and clinical signs are highly variable, ranging from aesthetic dissatisfaction to leg ulcers. The CEAP classification (clinical, etiological, anatomical, pathophysiological) enables the practitioner to precisely define chronic venous disease, providing a precise diagnostic description as well as enabling the patient to be monitored over time. Various quality-of-life scales have also been developed. Competing Interests: M. Josnin déclare avoir participé à des interventions ponctuelles pour Sigvaris, Mölnlycke Health Care, LEO Pharma, Aspen France, Urgo, Kreussler Pharma, Servier et Medtronic. N. Néaume déclare avoir participé à des interventions ponctuelles pour Medtronic, Biolitec, Urgo, Pfizer, BMS, Servier et Exeltis Santé. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|